{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:50:08Z","timestamp":1793418608420,"version":"4.5.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Bone turnover markers (BTMs) are biomedical indicators used to assess the bone metabolism processes reflecting the activity of osteoblasts and osteoclasts. During childhood and adolescence, bone metabolism is highly active, leading to distinct levels and trends of BTMs compared with those of adults. BTMs correlate significantly with age, gender and environmental factors, making them valuable for evaluating bone health and developmental trajectories in pediatric populations. Due to the non-invasive characters and dynamic monitoring capabilities, BTMs are increasingly employed in research and clinical practice. Preliminary observations propose that BTMs demonstrate clinical utility in predicting fracture risk, enabling early diagnosis of osteoporosis and rickets, and monitoring therapeutic efficacy. However, Tracability of BTM measurement results and limited pediatric reference intervals remain critical challenges. Further research is needed to expand our understanding of the their mechanisms and optimize clinical applications. This article reviews the physiological and pathological states in children, discusses the current dilemmas of clinical application, and highlights the future research prospects.<\/jats:p>","DOI":"10.3389\/fendo.2025.1615712","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:18:01Z","timestamp":1757477881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Advances in the application of bone turnover markers for pediatric growth and developmental disorders: a review"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5537182","DOI":"10.1155\/2023\/5537182","article-title":"Variation of bone turnover markers in childhood and adolescence","volume":"2023","author":"Zhang","year":"2023","journal-title":"Int J Clin Practice"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24656","article-title":"Broad application prospects of bone turnover markers in pediatrics","volume":"36","author":"Zhang","year":"2022","journal-title":"J Clin Lab analysis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-00964-2","article-title":"Bone turnover markers in children: from laboratory challenges to clinical interpretation","volume":"112","author":"Ladang","year":"2023","journal-title":"Calcified Tissue Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.880418","article-title":"The effect of BMI, age, gender, and pubertal stage on bone turnover markers in Chinese children and adolescents","volume":"13","author":"Cao","year":"2022","journal-title":"Front Endocrinology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2011.326","article-title":"Contribution of bone turnover markers to bone mass in pubertal boys and girls","volume":"24","author":"Gracia-Marco","year":"2011","journal-title":"J Pediat Endocrin Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocrine Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.10.1664","article-title":"Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development","volume":"14","author":"Mora","year":"1999","journal-title":"J Bone mineral Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"116221","DOI":"10.1016\/j.bone.2021.116221","article-title":"Novel serological biomarker models composed of bone turnover markers, vitamin D, and estradiol and their auxiliary diagnostic value in girls with idiopathic central precocious puberty","volume":"154","author":"Zhang","year":"2022","journal-title":"Bone"},{"key":"B9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpeds.2008.04.028","article-title":"Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease","volume":"153","author":"Tuchman","year":"2008","journal-title":"J pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20438","article-title":"Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: Comparison of megadose methylprednisolone and conventional-dose prednisolone treatments","volume":"80","author":"Alikasifoglu","year":"2005","journal-title":"Am J hematology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00353-7","article-title":"Structural and cellular changes during bone growth in healthy children","volume":"27","author":"Parfitt","year":"2000","journal-title":"Bone"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2485-4","article-title":"Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0\u201318 years","volume":"25","author":"Bayer","year":"2014","journal-title":"Osteoporosis Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes endocrinology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.03.007","article-title":"Role of bone turnover markers in osteoporosis therapy","volume":"50","author":"Jain","year":"2021","journal-title":"Endocrinol Metab Clinics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3390\/nu12103161","article-title":"Metabolomic associations with serum bone turnover markers","volume":"12","author":"Bellissimo","year":"2020","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/MOP.0b013e32833b0b9e","article-title":"Interpretation and application of bone turnover markers in children and adolescents","volume":"22","author":"J\u00fcrim\u00e4e","year":"2010","journal-title":"Curr Opin pediatrics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2019.60.12.1174","article-title":"Serum procollagen type I N-terminal propeptide and osteocalcin levels in Korean children and adolescents","volume":"60","author":"Choi","year":"2019","journal-title":"Yonsei Med J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1706","article-title":"Sex-and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years","volume":"92","author":"Rauchenzauner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01573.x","article-title":"Bone metabolism markers and bone mass in healthy pubertal boys and girls","volume":"57","author":"Van Coeverden","year":"2002","journal-title":"Clin endocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2049-z","article-title":"National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges","volume":"23","author":"Bauer","year":"2012","journal-title":"Osteoporosis Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.602","article-title":"International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis","volume":"49","author":"Vasikaran","year":"2011","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S8756-3282(02)00791-3","article-title":"Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting","volume":"31","author":"Qvist","year":"2002","journal-title":"Bone"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0631-6","article-title":"Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters","volume":"23","author":"Yilmaz","year":"2005","journal-title":"J Bone mineral Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s001980070116","article-title":"Biochemical measurements of bone turnover in children and adolescents","volume":"11","author":"Szulc","year":"2000","journal-title":"Osteoporosis Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/10408369409084677","article-title":"Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns","volume":"31","author":"Van Hoof","year":"1994","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4158\/EP161435.ESGL","article-title":"American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2014 2016\u2013executive summary","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocrine Practice"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.02.029","article-title":"Evaluation of different bone markers in hemodialyzed patients","volume":"371","author":"Cavalier","year":"2006","journal-title":"Clinica chimica Acta"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17843286.2020.1769285","article-title":"Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers","volume":"77","author":"Ladang","year":"2022","journal-title":"Acta Clinica Belgica"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2012.011274","article-title":"Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase","volume":"49","author":"Fischer","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2392","article-title":"Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects","volume":"121","author":"Christo","year":"2008","journal-title":"Pediatrics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05180-7","article-title":"Relationship between bone mineral content and bone turnover markers, sex hormones and calciotropic hormones in pre-and early pubertal children","volume":"31","author":"Z\u00fcrcher","year":"2020","journal-title":"Osteoporosis Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.10.002","article-title":"The 24-hour serum profiles of bone markers in healthy older men and women","volume":"120","author":"van der Spoel","year":"2019","journal-title":"Bone"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.5.859","article-title":"The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation","volume":"18","author":"Garnero","year":"2003","journal-title":"J Bone Mineral Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"115879","DOI":"10.1016\/j.bone.2021.115879","article-title":"Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (\u03b2-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP)","volume":"146","author":"Diemar","year":"2021","journal-title":"Bone"},{"key":"B36","doi-asserted-by":"publisher","first-page":"115124","DOI":"10.1016\/j.bone.2019.115124","article-title":"Children and adolescents with obesity have reduced serum bone turnover markers and 25-hydroxyvitamin D but increased parathyroid hormone concentrations\u2013results derived from new pediatric reference ranges","volume":"132","author":"Geserick","year":"2020","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.259085","article-title":"Bone turnover markers in the diagnosis and monitoring of metabolic bone disease","volume":"63","author":"Greenblatt","year":"2017","journal-title":"Clin Chem"},{"key":"B38","article-title":"Tartrate-resistant acid phosphatase\u2013TRAP 5b\u2013as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis","volume":"17","author":"Nowak","year":"2004","journal-title":"Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm.2018.07.03","article-title":"Bone markers and chronic kidney diseases","volume":"3","author":"Cavalier","year":"2018","journal-title":"J Lab Precis Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"116368","DOI":"10.1016\/j.bone.2022.116368","article-title":"The relationship between circulating hormone levels, bone turnover markers and skeletal development in healthy boys differs according to maturation stage","volume":"158","author":"Banica","year":"2022","journal-title":"Bone"},{"key":"B41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global consensus recommendations on prevention and management of nutritional rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporosis Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-012-0109-9","article-title":"Japanese 2011 guidelines for prevention and treatment of osteoporosis\u2013executive summary","volume":"7","author":"Orimo","year":"2012","journal-title":"Springer Open Choice"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-013-0495-0","article-title":"Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary","volume":"32","author":"Hwang","year":"2014","journal-title":"J Bone mineral Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-3906-6","article-title":"International osteoporosis foundation and european calcified tissue society working group. Recommendations for the screening of adherence to oral bisphosphonates","volume":"28","author":"Diez-Perez","year":"2017","journal-title":"Osteoporosis Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jocd.2019.03.004","article-title":"Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific region","volume":"24","author":"Wu","year":"2021","journal-title":"J Clin Densitometry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-017-0371-2","article-title":"Osteoporosis in children with chronic illnesses: diagnosis, monitoring, and treatment","volume":"15","author":"Grover","year":"2017","journal-title":"Curr Osteoporosis Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2007.12.003","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions","volume":"11","author":"Rauch","year":"2008","journal-title":"J Clin Densitometry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 Pediatric Position Development Conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin densitometry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24290","article-title":"Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation","volume":"24","author":"Davis","year":"2020","journal-title":"Health Technol Assess (Winchester England)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"116347","DOI":"10.1016\/j.bone.2022.116347","article-title":"Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation)","volume":"158","author":"Mattia","year":"2022","journal-title":"Bone"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-3949-8","article-title":"Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets","volume":"28","author":"Colares Neto","year":"2017","journal-title":"Osteoporosis Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.3390\/jcm11154622","article-title":"Bone turnover markers and bone mineral density in children with hypophosphatemic rickets","volume":"11","author":"Micha\u0142us","year":"2022","journal-title":"J Clin Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.782050","article-title":"Bone turnover markers in response to ultrasound-guided microwave ablation for primary hyperparathyroidism","volume":"12","author":"Ni","year":"2021","journal-title":"Front Endocrinology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s002230050004","article-title":"Bone ultrasonometry and turnover markers in primary hyperparathyroidism","volume":"66","author":"Cortet","year":"2000","journal-title":"Calcified Tissue Int"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3390\/cells10081895","article-title":"Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy","volume":"10","author":"Marini","year":"2021","journal-title":"Cells"},{"key":"B57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.18388\/abp.2017_2561","article-title":"Is it possible to predict a risk of osteoporosis in patients with juvenile idiopathic arthritis? A study of serum levels of bone turnover markers","volume":"65","author":"Janicka-Szczepaniak","year":"2018","journal-title":"Acta Biochim Polonica"},{"key":"B58","first-page":"54","article-title":"Bone mineral metabolism in children with juvenile idiopathic arthritis\u2013preliminary report","volume":"10","author":"G\u00f3rska","year":"2008","journal-title":"Ortopedia Traumatologia Rehabilitacja"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131107","article-title":"High adiposity and serum leptin accompanied by altered bone turnover markers in severe juvenile idiopathic arthritis","volume":"41","author":"Markula-Patjas","year":"2014","journal-title":"J Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.18544\/PEDM-21.04.0037","article-title":"Bone turnover markers in the obese children\u2013relation to gender, body composition and leptin level","volume":"21","author":"Matusik","year":"2015","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-01197-5","article-title":"Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus","volume":"89","author":"El Amrousy","year":"2021","journal-title":"Pediatr Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9261512","DOI":"10.1155\/2022\/9261512","article-title":"Bone density, geometry, and mass by peripheral quantitative computed tomography and bone turnover markers in children with diabetes mellitus type 1","volume":"2022","author":"Jaworski","year":"2022","journal-title":"J Diabetes Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.02.006","article-title":"Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study","volume":"38","author":"Delvin","year":"2019","journal-title":"Clin Nutr"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200010000-00012","article-title":"Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia","volume":"48","author":"Crofton","year":"2000","journal-title":"Pediatr Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1159\/000113063","article-title":"Serum bone turnover markers in patients with primary bone tumors","volume":"72","author":"Wang","year":"2008","journal-title":"Oncology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.145842","article-title":"Serum bone-specific alkaline phosphatase as a biomarker for osseous metastases in patients with Malignant carcinomas: a systematic review and meta-analysis","volume":"10","author":"Du","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards: osteoporos int","volume":"22","author":"Glendenning","year":"2011","journal-title":"Osteoporosis international"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s001980070004","article-title":"Preanalytical variability of biochemical markers of bone turnover","volume":"11","author":"Hannon","year":"2000","journal-title":"Osteoporosis Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0660-9","article-title":"Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis","volume":"19","author":"Szulc","year":"2008","journal-title":"Osteoporosis Int"},{"key":"B70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporosis Int"},{"key":"B71","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin Chem"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.12.1907","article-title":"Implementation of reference systems in laboratory medicine","volume":"46","author":"M\u00fcller","year":"2000","journal-title":"Clin Chem"},{"key":"B73","first-page":"97","article-title":"Traceability, reference systems and result comparability","volume":"28","author":"Panteghini","year":"2007","journal-title":"Clin Biochemist Rev"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2008.09.005","article-title":"Traceability and standardization of immunoassays: a major challenge","volume":"42","author":"Morris","year":"2009","journal-title":"Clin Biochem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2008.09.098","article-title":"Traceability as a unique tool to improve standardization in laboratory medicine","volume":"42","author":"Panteghini","year":"2009","journal-title":"Clin Biochem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cca.2020.12.023","article-title":"Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and \u03b2-CTX in blood","volume":"515","author":"Bhattoa","year":"2021","journal-title":"Clinica Chimica Acta"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00816-5","article-title":"A multicenter study to evaluate harmonization of assays for C-terminal telopeptides of type I collagen ([b\u00e9ta]-CTX): a report from the IFCC-IOF committee for bone metabolism (C-BM)","author":"Cavalier","year":"2021","journal-title":"Calcified Tissue Int."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4262","article-title":"Quantifying the balance between bone formation and resorption: An index of net bone formation","author":"Shieh","year":"2016","journal-title":"J Clin Endocrin Metab."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1615712\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:18:03Z","timestamp":1757477883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1615712\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":78,"alternative-id":["10.3389\/fendo.2025.1615712"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1615712","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"article-number":"1615712"}}